Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Update on MMJs investment in Harvest One (ASX:MMJ)

MMJ Group Holdings Limited (ASX:MMJ) ("MMJ"), an Australian-listed company that specialises inmanaging a portfolio of investments along the cannabis value-chain, is pleased to advise that,...read more

Noxopharm Investigating Potential COVID-19 Treatment (ASX:NOX)

Highlights: Hudson Institute identifies anti-inflammatory properties of idronoxil as consistent with blocking ‘cytokine storm’ believed responsible for many COVID-19 deaths Pre-clini...read more

Immutep AIPAC Phase IIb Clinical Results & Update Global Webcast Slides (ASX:IMM)

For the full slides, please download the attached PDF

Immutep reports supportive efficacy data from AIPAC study (ASX:IMM)

Highlights: Progression Free Survival (PFS) Hazard Ratio improvement for eftilagimod alpha (efti) group versusplacebo at the 6-month landmark Increased Overall Response Rate (ORR) of 48.3% in th...read more

Cyclopharm (ASX:CYC) Company Update (ASX:CYC)

COVID-19 Virus likely to increase use of Technegas® US FDA New Drug Application for Technegas – Application ready to submit to FDA Litigation – Statement of Claim Lodged with th...read more

Proposed issue of Securities - MMJ (ASX:MMJ)

For more information, please download the attached PDF

Immuteps Partner, EOC Pharma, Reports Completion of Recruitment of Phase I Study of EftImmuteps Partner, EOC Pharma, Reports Completion of Recruitment of Phase I Study of Efti (ASX:IMM)

Highlights: Last patient enrolled and safely dosed, completing patient recruitment for EOC Pharma’s phase I studyin metastatic breast cancer (MBC) Data expected throughout 2020, with study c...read more

MMJ Investor Update - WeedMD (ASX:MMJ)

MMJ Group Holdings Limited (ASX:MMJ) ("MMJ"), an Australian-listed company that specialises in managing a portfolio of investments along the cannabis value-chain, attaches the following rele...read more

Oventus Medical - Strategic response to COVID-19 (ASX:OVN)

Obstructive Sleep Apnoea (OSA) treatment innovator, Oventus Medical Ltd (ASX: OVN) wishes to provide a short update on operating conditions in light of COVID-19. Over the past 48 hours, a number ...read more

Noxopharm Announces Veyonda Awarded First Allowed Patent Application (ASX:NOX)

Noxopharm (NOX:ASX) announces that Australian patent application No. 2016401508 has been allowed by the Australian Patent Office. The patent claims are directed to a suppository formulation includin...read more

MMJ SPP Reduction in SPP Offer Price (ASX:MMJ)

MMJ Group Holdings Limited (ASX: MMJ) ("MMJ" or “the Company”), an Australian-listed company that specialises in managing a portfolio of investments along the cannabis value-ch...read more

Update on Progress in Nyrada Programs (ASX:NYR)

Highlights: Two lead R&D programs progressing as planned and on-budget Brain injury program leads to discovery of a new generation of more potent drug candidates PCSK9 (cholesterol-lowerin...read more

MMJ Group Holdings - net tangible asset backing as at 29 February 2020 (ASX:MMJ)

MMJ Group Holdings Limited (ASX: MMJ) ("MMJ") is required to announce its net tangible assets (“NTA”) per share pursuant to Listing Rule 4.12. Accordingly, please find enclosed...read more

MMJ Group Holdings - update on loan to Harvest One (ASX:MMJ)

MMJ Group Holdings Limited (ASX:MMJ) ("MMJ"), an Australian listed company that specialises in managing a portfolio of investments along the cannabis value-chain, is pleased to advise that...read more

MMJ Group Holdings announces WeedMe capital raising (ASX:MMJ)

MMJ Group Holdings Limited (ASX:MMJ) ("MMJ"), an Australian listed company that specialises in managing a portfolio of investments along the cannabis value-chain, advises that the private ...read more

Viewing: 1 - 15 of 200 Previous | Next